中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
CHINESE JOURNAL OF ANESTHESIOLOGY
2010年
4期
437-440
,共4页
申帮利%黄匆匆%陈果%李军%宋学军%连庆泉%曹红
申幫利%黃匆匆%陳果%李軍%宋學軍%連慶泉%曹紅
신방리%황총총%진과%리군%송학군%련경천%조홍
硫胺素%维生素B6%维生素B12%糖尿病神经病变
硫胺素%維生素B6%維生素B12%糖尿病神經病變
류알소%유생소B6%유생소B12%당뇨병신경병변
Thiamine%Vitamin B6%Vitamin B12%Diabetic neuropathies
目的 探讨B族维生素(维生素B1、B6、B12)对大鼠糖尿病神经病理性痛(DNP)的效应.方法 雄性SD大鼠104只,体重200~230 g,随机分为13组(n=8):正常对照组(C组),DNP组,DNP+生理盐水组(NS组),DNP+维生素B110、33、100 mg/kg组(B1 10组、B133组、B1100组),DNP+维生素B610、33、100 mg,kg组(B610组、B633组、B6100)组),DNP+维生素B120.5、1.5、4.5 mg/kg组(B120.5组、B12 1.5组、B124.5组),DNP+维生素B1 10/B6 33/B12 1.5 mg,kg组(VBC组).除C组外,其余各组均采用腹腔注射链唑霉素75 mg/kg 的方法制备DNP模型,于注射链唑霉素前2 d、注射后14 d时测定机械缩足阈值(MWT)和热缩足潜伏期(TWL),MWT和TWL均低于基础值的85%为DNP模型制备成功.注射链唑霉素后14 d时腹腔注射相应剂量和种类的B族维生素或生理盐水,1次/d,连续2周,并于B族维生寨给药1、3、7、14 d时测定MWT和TWL,最后1次测定痛阈后处死大鼠,测定脊髓背角和背根神经节(DRG)磷酸化cAMP反应元件结合蛋白(p-CREB)的表达水平.结果 与C组相比,其余各组MWT降低,TWL缩短,脊髓背角和DRG p-CREB表达上调(P<0.05);与DNP组比较,各B族维生素组MWT升高,TWL延长,脊髓背角和DRG p-CREB表达下调,且呈剂量依赖性(P<0.05);与B110组、B633组、B121.5组比较,VBC组MWT升高,TWL延长,脊髓背角和DRG p-CREB表达下调(P<0.05).结论 B族维生素可减轻大鼠DNP,呈剂量依赖性,其机制可能与抑制脊髓背角和DRG CREB 的磷酸化有关.
目的 探討B族維生素(維生素B1、B6、B12)對大鼠糖尿病神經病理性痛(DNP)的效應.方法 雄性SD大鼠104隻,體重200~230 g,隨機分為13組(n=8):正常對照組(C組),DNP組,DNP+生理鹽水組(NS組),DNP+維生素B110、33、100 mg/kg組(B1 10組、B133組、B1100組),DNP+維生素B610、33、100 mg,kg組(B610組、B633組、B6100)組),DNP+維生素B120.5、1.5、4.5 mg/kg組(B120.5組、B12 1.5組、B124.5組),DNP+維生素B1 10/B6 33/B12 1.5 mg,kg組(VBC組).除C組外,其餘各組均採用腹腔註射鏈唑黴素75 mg/kg 的方法製備DNP模型,于註射鏈唑黴素前2 d、註射後14 d時測定機械縮足閾值(MWT)和熱縮足潛伏期(TWL),MWT和TWL均低于基礎值的85%為DNP模型製備成功.註射鏈唑黴素後14 d時腹腔註射相應劑量和種類的B族維生素或生理鹽水,1次/d,連續2週,併于B族維生寨給藥1、3、7、14 d時測定MWT和TWL,最後1次測定痛閾後處死大鼠,測定脊髓揹角和揹根神經節(DRG)燐痠化cAMP反應元件結閤蛋白(p-CREB)的錶達水平.結果 與C組相比,其餘各組MWT降低,TWL縮短,脊髓揹角和DRG p-CREB錶達上調(P<0.05);與DNP組比較,各B族維生素組MWT升高,TWL延長,脊髓揹角和DRG p-CREB錶達下調,且呈劑量依賴性(P<0.05);與B110組、B633組、B121.5組比較,VBC組MWT升高,TWL延長,脊髓揹角和DRG p-CREB錶達下調(P<0.05).結論 B族維生素可減輕大鼠DNP,呈劑量依賴性,其機製可能與抑製脊髓揹角和DRG CREB 的燐痠化有關.
목적 탐토B족유생소(유생소B1、B6、B12)대대서당뇨병신경병이성통(DNP)적효응.방법 웅성SD대서104지,체중200~230 g,수궤분위13조(n=8):정상대조조(C조),DNP조,DNP+생리염수조(NS조),DNP+유생소B110、33、100 mg/kg조(B1 10조、B133조、B1100조),DNP+유생소B610、33、100 mg,kg조(B610조、B633조、B6100)조),DNP+유생소B120.5、1.5、4.5 mg/kg조(B120.5조、B12 1.5조、B124.5조),DNP+유생소B1 10/B6 33/B12 1.5 mg,kg조(VBC조).제C조외,기여각조균채용복강주사련서매소75 mg/kg 적방법제비DNP모형,우주사련서매소전2 d、주사후14 d시측정궤계축족역치(MWT)화열축족잠복기(TWL),MWT화TWL균저우기출치적85%위DNP모형제비성공.주사련서매소후14 d시복강주사상응제량화충류적B족유생소혹생리염수,1차/d,련속2주,병우B족유생채급약1、3、7、14 d시측정MWT화TWL,최후1차측정통역후처사대서,측정척수배각화배근신경절(DRG)린산화cAMP반응원건결합단백(p-CREB)적표체수평.결과 여C조상비,기여각조MWT강저,TWL축단,척수배각화DRG p-CREB표체상조(P<0.05);여DNP조비교,각B족유생소조MWT승고,TWL연장,척수배각화DRG p-CREB표체하조,차정제량의뢰성(P<0.05);여B110조、B633조、B121.5조비교,VBC조MWT승고,TWL연장,척수배각화DRG p-CREB표체하조(P<0.05).결론 B족유생소가감경대서DNP,정제량의뢰성,기궤제가능여억제척수배각화DRG CREB 적린산화유관.
Objective To evaluate the effect of B-vitamins(B1,B6,B12)on diabetic neuropathic pain (DNP)in rats.Methods 104 male SD rals weighing 200-230 g were randomly divided into 13 groups(n=8 each):group Ⅰ control(group C);group Ⅱ DNP;group Ⅲ DNP+ normal saline(solvent of vitamins,group NS);group Ⅳ,Ⅴ,Ⅵ DNP+vitamin B1 10,33 or 100mg/kg,kg(group B1 10,group B133,group B1 100);group Ⅶ,Ⅷ,Ⅺ DNP+vitamin B6 10,33 or 100 mg/kg(group B6 10,group B633,group B6100);group Ⅹ,Ⅲ,ⅫDNP+vitamin B12 0.5,1.5 or 4.5 mg/kg (group B12 0.5,group B121.5,group B124.5)and group ⅩⅢ DNP+vitamin B1 10/B6 33/B12 1.5 mg/kg(group VBC).Diabetes was induced with intraperitoneal(IP) streptozocin mg/kg in group Ⅱ-ⅩⅢ.B-vitamins were give.IP once a day for 14 consecutive days starting from 14 d after IP streptozocin in group Ⅳ-ⅩⅢ.Venous blood samples were taken before(baseline)and 3 d after IP streptozocin for determination of blood glucose level. Successful induction of diabetes was defined as blood glucose > 14.6 mmol/L. Mechanical paw withdrawal threshold to yon Frey stimuli (MWT) and paw withdrawal latency to thermal nociceptive stimulus (TWL) were measured 2 days before and 14 days after IP streptozocin and on the 1, 3, 7, 14 days of B-vitamin administration. Animals with pain threshold measured at 14 days after IP streptozocin decreasing by less than 15% of the baseline were excluded from the study. The animals were sacrificed after the last pain threshold measurement and L4,5 lumbar segment of the spinal cord and dorsal root ganglions (DRG) were removed for determination of p-CREB expression using immuno-histuchemistry. Results MWT was significantly lower and TWL was significantly shorter and the expression of p-CREB was significantly higher in the other groups than in group C. B-vitamin administration significantly reduced thermal and mechanical hyperalgesia induced by diabetes and down-regulated the expression of p-CREB in a dose-dependent manner as compared with group DNP. The inhibitory effect of vitamin B complex against thermal and mechanical hyperalgesia was significantly stronger and the expression of p-CREB was significantly lower in group VBC as compared with group B110, group B633 and group B121 .5 respectively. Conclusion B-vitamains can attenuate DNP through inhibition of phospberylation of CREB in the spinal dorsal horn and DRG.